<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T02:02:01Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/18976" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/18976</identifier><datestamp>2026-09-24T03:40:41Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Ashkar, Ali A</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author">Shenouda, Mira M</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Medical Sciences (Molecular Virology and Immunology Program)</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2016-03-22T16:13:22Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2016-03-22T16:13:22Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2016</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/18976</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/25338</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">Natural killer (NK) cells have the ability to recognize and kill cancer and virally infected  cells,  yet  spare  healthy  cells;  thus,  they  play  a  critical  role  in  cancer immunosurveillance. Recent developments have allowed for  ex-vivo  expansion of NK cells into millions of cells from a small volume of peripheral blood, thus clearing a major hurdle in the field of adoptive NK cell immunotherapy. We explored  the use of ex-vivo  expanded NK cells as an  autologous  cell therapy for breast cancer. The main focus of our study is to  assess the functionality  and phenotype of  ex-vivo  expanded NK  cells  from  breast  cancer  patients.  Moreover,  we  tested  the  functionality  of expanded NK cells both  in vitro  and  in vivo,  using a xenograft mouse model, against breast  cancer  cell  lines.  Finally,  we  investigated  the  potential  use  of  cytokines  to further activate  expanded NK cells.  Thus, we expanded  NK cells from both healthy donors and cancer patients and examined their expression of different surface markers. After  three  weeks  of  culture  we  observed  an  expansion  of  more  than  one  thousand fold  of  NK  cell  isolated  from  either  breast  cancer  patients  or  healthy  donors.  Our results  also  show  that  the  phenotype  of  ex-vivo  expanded  NK  cells  from  cancer patients is comparable to expanded healthy donors’ NK cells. Moreover, our results confirm the ability of these NK cells to lyse both  tumour  cell lines  in vitro.  In our  in vivo  model, we were able to demonstrate that NK cells  are capable of  preventing the establishment  and  growth  of  the  tumour  in  immunocompromised  mice.  Finally,  we showed that  cytokine activation of expanded NK cells can potentially increase their cytotoxic ability against the HER2 positive cell line; however  we saw no difference in their  cytotoxicity  against  the  triple  negative  cell  line.  Thus  far,  we were  able  to demonstrate  that  NK  cells  from  breast  cancer  patients  can  be  expanded  similarly  to those  from  healthy  donors  and  these  NK  cells  also  have  a  high  cytotoxic  ability against  breast  cancer  cell  lines.  Furthermore,  cytokine activation  of  expanded  NK cells can be beneficial against some breast cancer subtypes.</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degreetype" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Master of Science (MSc)</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en_US">en</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">PHENOTYPE AND FUNCTIONALITY OF NATURAL KILLER CELLS EXPANDED FROM BREAST CANCER PATIENTS AND HEALTHY DONORS AGAINST BREAST CANCER CELL LINES</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>